32949-41-0

Basic information

• Product Name: (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid
• Synonyms: (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid
• CAS NO: 32949-41-0
• Molecular Weight: 455.514
• Mol File: 32949-41-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid(32949-41-0)
• EPA Substance Registry System: (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid(32949-41-0)

Safety Data

• Hazardous Substances Data: 32949-41-0(Hazardous Substances Data)

Usage

Description

(S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid is a complex peptide and amino acid derivative characterized by its chiral (S) configuration and optical activity. (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid is composed of a unique arrangement of amino acids and guanidino groups, making it a promising candidate for pharmaceutical and biochemical research.

Uses

Used in Pharmaceutical Research:
(S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid is used as a therapeutic agent for various diseases and medical conditions. Its specific peptide sequence and guanidino functionality contribute to its potential in drug development and research into physiological processes.
Used in Biochemical Research:
In the field of biochemistry, (S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid serves as a valuable molecule for studying the interactions and mechanisms of various biological systems. Its unique structure allows researchers to explore its potential applications in understanding and modulating biological functions.
Used in Drug Development:
(S)-2-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-5-guanidinopentanoic acid is also utilized in drug development due to its potential as a therapeutic agent. Its specific geometric arrangement and functional groups make it an attractive candidate for the design and synthesis of novel drugs targeting various diseases and medical conditions.

Upstream product

• 74-79-3 L-arginine 
• 17543-49-6 (S)-benzyloxycarbonylphenylalanine pentafluorophenyl ester 
• 769922-77-2 (S)-benzyl (1-(1H-benzo[d][1,2,3]triazol-1-yl)-1-oxo-3-phenylpropan-2-yl)carbamate 
• 3397-32-8 N-(benzyloxycarbonyl)-phenylalanine-N-hydroxysuccinimide ester 
• 170713-34-5 C₃₃H₃₆N₆O₆ 

Downstream Products

• 74-79-3 L-arginine 
• 1161-13-3 N-Cbz-L-Phe 
• 119460-01-4 (S)-2-[(S)-2-((S)-2-{(S)-2-[(S)-3-(Acetylamino-methylsulfanyl)-2-tert-butoxycarbonylamino-propionylamino]-3-carbamoyl-propionylamino}-3-hydroxy-propionylamino)-3-phenyl-propionylamino]-5-guanidino-pentanoic acid 
• 125510-00-1 (S)-2-[(S)-2-((S)-2-{(S)-2-[(S)-3-(Acetylamino-methylsulfanyl)-2-amino-propionylamino]-3-carbamoyl-propionylamino}-3-hydroxy-propionylamino)-3-phenyl-propionylamino]-5-guanidino-pentanoic acid 
• 119460-00-3 (S)-2-{(S)-2-[(S)-3-tert-Butoxy-2-((S)-2-tert-butoxycarbonylamino-3-carbamoyl-propionylamino)-propionylamino]-3-phenyl-propionylamino}-5-guanidino-pentanoic acid 
• 119459-99-3 (S)-2-[(S)-2-((S)-2-Benzyloxycarbonylamino-3-tert-butoxy-propionylamino)-3-phenyl-propionylamino]-5-guanidino-pentanoic acid 
• 119439-70-2 C₅₈H₉₅N₁₇O₁₉S 
• 1238-09-1 L-phenylalanyl-L-arginine 
• 195521-93-8 Z-Ala-Phe-Arg-OH 
• 116685-18-8 Ala-Phe-Arg 
• 195522-05-5 Boc-Cys(Acm)-Ala-Phe-Arg-Gln-Val-Cys(Acm)-NHEt 
• 195521-95-0 Boc-Cys(Acm)-Ala-Phe-Arg-OH 
• 803706-22-1 Z-Asp(OBzl)-Phe-Arg-OH 

Relevant articles and documents

Bottom-Up Construction of an Adaptive Enzymatic Reaction Network

The reproduction of emergent behaviors in nature using reaction networks is an important objective in synthetic biology and systems chemistry. Herein, the first experimental realization of an enzymatic reaction network capable of an adaptive response is reported. The design is based on the dual activity of trypsin, which activates chymotrypsin while at the same time generating a fluorescent output from a fluorogenic substrate. Once activated, chymotrypsin counteracts the trypsin output by competing for the fluorogenic substrate and producing a non-fluorescent output. It is demonstrated that this network produces a transient fluorescent output under out-of-equilibrium conditions while the input signal persists. Importantly, in agreement with mathematical simulations, we show that optimization of the pulse-like response is an inherent trade-off between maximum amplitude and lowest residual fluorescence.

Dipeptidyl-α,β-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain

The dipeptidyl epoxyesters 3 and 4 are potent, irreversible inhibitors of cruzain and rhodesain.

Synthesis of Ethylamide of Cyclic Undecapeptide Corresponding to the 593 - 603 Sequence of Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type Two

Ethylamide of cyclic disulfide of the HIV-2 peptide antigen corresponding to the 593 - 603 sequence of the gp41 protein was synthesized by conventional methods of peptide chemistry in solution.The absence of racemization during fragment condensation was s